Seeking Alpha

Chemistfrog

 
View Chemistfrog's StockTalks BY TICKER:
  • Chemistfrog
    Interview With Fabrus President Dr. Vaugh Smider $SNTI http://seekingalpha.com/a/15nnj
    Jan 14, 5:01 AM
    Reply (2)
    • petethepanzer: with snti your buying half a share since you only own 50% of each company with each share purchased...how is this is good for topline data
      Jan 14, 6:17 AM
    • 146: 1 divided by 2 is not absolutely .5 depending on synergies. I suspect, presently not enough info is out to determine either way.
      Jan 15, 2:45 PM
      • Chemistfrog
        Imminent Catalysts Should Keep Investor Interest Strong For Venaxis In 2014 $APPY http://seekingalpha.com/a/15695
        12/30/13
        Reply
          • Chemistfrog
            Been buying safer stocks as of late. Work is too busy to babysit volatile pennies except for very small positions.
            5/22/13
            Reply (5)
          • View all 5 replies
            • Chemistfrog: Wow.. Good luck and be careful sir. Sell some on the way up to secure gains in my opinion.. Best of luck ahead! Vacation here I come! :)
              5/22/13
            • joe kelly: Success to you as well. Your research has been a great tool.
              5/23/13
              • Chemistfrog
                Watching metals #silver & #gold closely. Specifically trading $GDXJ, $GDX and $USLV. #oversold?
                5/22/13
                Reply
                  • Chemistfrog
                    Loving how biotechs have been performing! However, be careful. If market tops, the big runners drop hardest...
                    5/22/13
                    Reply
                      • Chemistfrog
                        Strong move again by $ACRX today! $7.26 PPS with $270 million market cap!
                        5/22/13
                        Reply
                          • Chemistfrog
                            $BIOD should continue garnering interest up to the P2 data release. Strong move in the last week!
                            5/22/13
                            Reply
                              • Chemistfrog
                                $GLD I'm still bullish here! Will sell to reduce at $143 and $149, while holding rest w/trailing stop limits..
                                4/28/13
                                Reply (3)
                              • View all 3 replies
                                • Chemistfrog: LOL! How did NUGT go? Sold my $GLD at 142 when it appeared to be struggling and chart was looking scary... Considering a $JJC entry...
                                  5/4/13
                                • Chemistfrog: Considering a 50/50 position mix in $GDX and $GDXJ, or adding $GLD back into the mix as well. Any opinions?
                                  5/6/13
                                  • Chemistfrog
                                    $SUPN I believe entry down here is wise. Q1 financials could really give the company momo.. Final approval for Trokendi in June/July
                                    4/20/13
                                    Reply (2)
                                    • joe kelly: You have any opinion on cytk? Keeps coming up on my radar along with supn.
                                      4/20/13
                                    • Chemistfrog: $CYTK chart is in breakout mode. Many catalysts ahead for 13. Watch earnings release for phase IIb update.. I like the company. Good future.
                                      4/20/13
                                      • Chemistfrog
                                        $ACRX simply looks "ready" :) Q2 data is imminent...
                                        4/20/13
                                        Reply
                                          • Chemistfrog
                                            $INO traded down due to poor data from collaborator using their own DNA. Updates on the company using their own DNA could really push it up
                                            4/20/13
                                            Reply
                                              • Chemistfrog
                                                $APPY sold off a bit last week and recovered Friday. I sold 1/2 into strength and am holding remainder..
                                                4/20/13
                                                Reply
                                                  • Chemistfrog
                                                    $CTSO is an exciting small company. Cytosorb is approved in Europe. Any IND filings for US clinicals would be huge..
                                                    4/20/13
                                                    Reply
                                                      • Chemistfrog
                                                        $AAPL is another one of those that I believe has been bashed down to current levels. I believe it wise to start accumulating here & lower..
                                                        4/20/13
                                                        Reply
                                                          • Chemistfrog
                                                            $TROV sold off last week. I accumulated a bit more as I can't believe it is down here. Looking for company updates..
                                                            4/20/13
                                                            Reply
                                                              • Chemistfrog
                                                                $SNRE still illiquid, but I believe it is HIGHLY UNDERVALUED. I have a small position but will add on any + clinical updates.
                                                                4/20/13
                                                                Reply
                                                                  • Chemistfrog
                                                                    $BIOD looking strong. I will continue to accumulate here, but would LOVE to see $2.50 before run up to September data release.
                                                                    4/20/13
                                                                    Reply
                                                                      • Chemistfrog
                                                                        $PAY I cannot see this dropping from these levels. watching to see if immediate inverse head-and-shoulders, bleed down or gradual recovery.
                                                                        2/21/13
                                                                        Reply
                                                                          • Chemistfrog
                                                                            $ACRX looks to be consolidating for the next leg up. Before or after 1Q data release? $DARA with many imminent catalysts
                                                                            2/5/13
                                                                            Reply
                                                                              • Chemistfrog
                                                                                EXEL should start getting a lot of serious attention going into 11/29 PDUFA cabozantinib. Priority review.. $EXEL
                                                                                9/28/12
                                                                                Reply